Contact
Home • About us • Our story

Our story.

Discover the story behind our beginnings and vision for the future.

Learn how we can help you

From humble beginnings to a leader in life science consulting.

Putnam has been a leader in life science consulting for over 30 years. We’re an Inizio Advisory company, known within our ecosystem for helping our clients build value and make confident decisions.

Today, our comprehensive suite of services across commercial, value, pricing, and access, and medical and scientific affairs are supporting our firm’s mission and our clients’ success.

By the numbers.

What started as a small but mighty consulting group has grown into a leading scientific and strategic consulting partner with:

400+

Team members

Our growing global team is 100% focused on life sciences with deep industry experience and niche expertise.

10

10 global offices

We continue to expand our global footprint to deliver more local presence, perspective, and value to clients.

45+

Therapeutic areas

Deep expertise across more than 45 therapeutic areas.
1988
Founded

Founded as a strategy consulting firm for the life sciences industry

2013
Milestone

New phase begins as a new wave of management implements a new vision for growth

2015
New offices

San Francisco office opens

2017

New partners join the management team; named #1 boutique consulting firm by Vault

2019
Milestone

Joined Ashfield Advisory Group and positioned for continued growth

2020
New offices

NYC and London offices open; growing offerings for Value, Pricing & Access and Data Analytics

2021
Milestone

PHMR joins and grows Putnam’s Value, Pricing & Access practice area

2022
Milestone

Huntsworth and Ashfield unite as Inizio; Putnam welcomes SmartAnalyst and Creativ-Ceutical

Meet our experts.

At Putnam, our global team of rigorously trained and highly engaged scientists and strategists dig deep to solve your most complex challenges and advance your innovations.

Get to know our people

Who we are

Leading industry partner.

We are a leading scientific and strategic consulting partner that helps the global life science community make confident decisions, build value, and bring life-changing innovations to clinicians and patients. ​

For more than 30 years, our rigorous, bespoke approach and globally diverse team have delivered unrivalled depth across therapeutic areas, business functions, geographic markets, healthcare sectors, and technology platforms to maximize the human impact and commercial success of client innovations.

About usOur expertise

What we do.

Putnam bridges the highest levels of scientific and strategic excellence across the product development and commercialization lifecycle. We offer a breadth and depth of capabilities across areas.

Tap to view Commercial

Commercial

Commercial
Tap to view Value, Pricing & Access

Value, Pricing & Access

Value, Pricing & Access
Tap to view Medical & Scientific Affairs

Medical & Scientific Affairs

Medical & Scientific Affairs

Centers of Excellence.

We help you navigate complexities and develop bold strategies with centers of excellence in advanced clinical technologies, financial modeling and forecasting, and integrated insights.

See our Centers of Excellence

Inizio Advisory.

Inizio Advisory is a trusted advisor for health and life science companies that leverages connected solutions and intelligence to turn science into strategy and execution for every stage of the journey from early commercialization to product launch and beyond.

Explore the full Inizio family

Latest thinking.

Get the latest insights and perspectives from our experts.

View all of our resources

Leading world-class Medical Affairs into the future: Insights from Putnam’s Medical Affairs Leadership Council (Spring 2024)

We recently reconvened our Medical Affairs Leadership Council, discussing top of mind topics with leaders.

Read more

Putnam announces new Partner promotions

Putnam, leading scientific and strategic consulting partner, is thrilled to announce Scott Briggs and Thomas Marder have been promoted to Partner...

Read more

Integrating market access considerations into biopharmaceutical asset investment decisions: Common pain points and best practices

Best practices for navigating challenges in integrating market access into investment decision-making.

Read more

BD&L strategy for oncology leadership

Our experts take a deep dive into the growing oncology market uncovering the top drivers and activities of revenue growth.

Read more